期刊文献+

线粒体融合蛋白2与心血管疾病 被引量:8

Mitochondrial Fusion Protein Mfn2 and Cardiovascular Diseases
下载PDF
导出
摘要 线粒体融合蛋白2(mitofusin2,Mfn2)不仅是一种不可或缺的调控线粒体形态和功能的动力素(dynamin)相关蛋白,还是一个重要的细胞内信号分子,参与调控细胞增殖、分化、凋亡等生命过程。Mfn2与高血压、冠状动脉腔内成形术后再狭窄、动脉粥样硬化、心肌肥厚、心肌氧化损伤等多种心血管疾病的病理生理过程密切相关,并通过调节物质代谢影响糖尿病和胰岛素抵抗等的发病。此外,Mfn2还可能是心血管疾病的一个重要的分子标志和治疗靶分子。 Mitofusin 2 (Mfn2)is a mitochondrial dynamin-related protein involved in the mitochondrial fusion reaction and is also connected to an altered mitochondrial energy supply. Mfn2 is a signaling molecule, plays an important role in cell proliferation, differentiation and apoptosis, which participates in the pathophysiology of several cardiovascular diseases, such as hypertension, restenosis after angioplasty, ath- erosclerosis, cardiac hypertrophy, and cardiac oxidative stress injury. Regulating the mitochondria-related metabolism, Mfn2 affects diabetes and insulin resistance pathogenesis. In addition, Mfn2 could be an im- portant biomarker and therapeutic target molecule for cardiovascular diseases.
出处 《生理科学进展》 CAS CSCD 北大核心 2010年第1期11-16,共6页 Progress in Physiological Sciences
基金 国家高技术研究发展计划(863计划 2008AA02Z441) 高等学校博士学科点专向科研基金(20060001143)资助课题
关键词 线粒体融合蛋白2 心血管疾病 增殖 凋亡 信号转导 mitofusin 2 cardiovascular diseases proliferation apoptosis cell signaling
  • 相关文献

参考文献20

  • 1陈光慧,张晨晖,朱燕青,董纲,周爱儒,马大龙,汤键.一个新的高血压病相关基因的克隆和表达[J].中华医学杂志,1997,77(11):823-828. 被引量:45
  • 2Chen KH, Guo X, Ma D, et al. Dysregulation of HSG triggers vascular proliferative disorders. Nat Cell Biol,2004,6 : 872 - 883.
  • 3Santel A, Fuller M. Control of mitochondrial morphology by a human mitofusin. J Cell Sci ,2001,114 : 867 - 874.
  • 4Li Y, Yin R, Liu J, et al. Peroxisome proliferator-activated receptor δ regulates mitofusin 2 expression in the heart. J Mol Cell Cardiol, 2009, 46 : 876- 882.
  • 5Soriano FX, Liesa M. Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator activated receptor-3, coactivator-1α, estrogen-related receptor α, and mitofusin 2. Diabetes, 2006, 55 : 1783 - 1791.
  • 6Guo X, Chen KH, Guo Y, et al. Mitofusin 2 triggers vascular smooth muscle cell apoptosis via mitochondrial death pathway. Circ Res,2007,101 : 1113 - 1122.
  • 7Pawlikowska P, Gajkowska B, Orzechowski A. Mitofusin 2 (Mfn2) : a key player in insulin-dependent myogenesis in vitro. Cell Tissue Res,2007,327 : 571 -581.
  • 8Huang P, Yu T, Yoon Y. Mitochondrial clustering induced by overexpression of the mitochondrial fusion protein Mfn2 causes mitochondrial dysfunction and cell death. Eur J Cell Biol. 2007,86 : 289 - 302.
  • 9Shen T, Zheng M, Xiao RP, et al. Mitofusin-2 is a major determinant of oxidative stress-mediated heart muscle cell apoptosis. J Biol Chem,2007,282 : 23354 -23361.
  • 10Jiang GJ, Han M, Zheng B, et al. Expression and function of hypertension related gene hrg-1 during redifferentiation of vascular smooth muscle cells. Heart Vessels ,2006,21 : 315 320.

二级参考文献26

  • 1李鹏飞,郭艳红,李黔,姚蓬英,陈光慧.腺病毒介导的rHSG-1基因转染对自发性高血压大鼠血管平滑肌细胞增殖的影响[J].北京大学学报(医学版),2004,36(3):259-262. 被引量:11
  • 2杨亚东,李倩虹,张新波.原发性高血压相关基因的研究进展[J].中国高血压杂志,1993,1(1):1-4. 被引量:7
  • 3Chen KH, Wang F, Zhang J, et al. Cloning and expression of novel cDNA related to hyperpertension. Chin Med J, 1998,111:383-384.
  • 4Chen KH ,Guo X,Ma D,et al. Dysregulation of HSG triggers vascular proliferative disorders. Nat Cell Biol,2004,6:872-883.
  • 5Santel A, Fuller MT. Control of mitochondrial morphology by a human mitofusin. J Cell Sci,2001,114 (Pt 5) :867-874.
  • 6Vita JA, Keaney JF Jr. Endothelail function: a barometer for cardiovascular risk? Circulation ,2002,106:640-642.
  • 7Linds L, Granstma SO, Millgard J. Endothelium-dependent vasodilation in hypertension:a review. Blood Press,2000,9:4-15.
  • 8Puddu P, Puddu GM, Zaca F, et al. Endothelial dysfunction in hypertension. Acta Cardiol, 2000,55:221-232.
  • 9Yang T X,Hypertension,1996年,27卷,541页
  • 10Gao Y Q,Chin J Hypert,1994年,2卷,18页

共引文献65

同被引文献85

  • 1Jiang GJ,Han M,Zheng B, et al. Hyperplasia suppressor gene as-sociates with smooth muscle alpha-actin and is involved in the redif-ferentiationof vascular smooth muscle cells. Heart Vessels, 2006 ,21(5):315-320.
  • 2Guo X,Chen KH,Guo Y,et al. Mitofusin 2 triggers vascularsmooth muscle cell apoptosis via mitochondrial death pathway. CircRes, 2007,101(11) :1113-1122.
  • 3Chen G, Liu N, Zhou A, et al. The role of hypertension-relatedgene in aortic vascular smooth muscle cells from mice and rats.Chin Med J (Engl) , 2001,114(8) :833-836.
  • 4Chien KR, Hoshijima M. Unravelling Ras signals in cardiovasculardisease. Nat Cell Biol, 2004,6(9) :807-808.
  • 5Sauvanet C, Duvezin-Caubet S, di Rago J P, et al. Energetic requirements and bioenergetic modulation of mitochondrial morphology and dynamics[J]. Semin Cell Dew 13iol, 2010,21 (6) :558 - 565.
  • 6Chen L,Knowlton AA. Mitochondrial dynamics in heart failure [J]. Congest Heart Fail,2011,17(6):257 261.
  • 7Horn J, Sheu SS. Morphological dynamics of mitochondria a special emphasis on cardiac muscle cells[J] J Mol Cell Cardiol, 2009,46(6) :811 - 820.
  • 8Chen H, Chomyn A, Chan DC. Disruption of fusion results in mitochondrial heterogeneity and dysfunction[J] J Biol Ckem,2005,280(28) :26185 - 26192.
  • 9Chen H,Detmer SA, Ewald AJ,et al. Mitofusins Mfnl and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development [J] J Cell Biol, 2003,60(2) : 189 - 200.
  • 10Cipolat S,Martins de Brito O, DaI Zilio B, et al. OPAl requires mitofusin 1 to promote mitochondrial fusion [J]. Proc Natl Acad Sci,2004,101(45) :15927- 15932.

引证文献8

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部